Michael Kinch, PhD
Michael S. Kinch is Dean of Science, Vice President for Innovation and director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Long Island University. He is the author of Between Hope and Fear: A History of Vaccines and Human Immunity, The End of the Beginning: Cancer, Immunity and the Future of a Cure and A Prescription for Change: The Looming Crisis in Drug Development.
Egg on Our Face: Another Asilomar Moment?
Michael Kinch confronts a recent controversy in the field of immunology, where researchers failed to seek permission or guidance from the NIAID before engineering mutant forms of SARS-CoV-2.
A Degeneration of Trust
Recently, an expose article was published revealing a potential fabrication of data by prominent investigators of Alzheimer’s disease. In this op-ed piece, Michael Kinch explores the catastrophic impact of scientific fraud.
The Vaccination Divide: Where Pathogens Meet Politics
In this opinion article, Michael S Kinch considers the links between vaccination skepticism and politics, sentiments that were deeply entrenched in society before the first vaccine was discovered in the eighteenth century.
Why Ever More Boosters Could Hurt More Than Help
In this opinion article, Michael S Kinch explains why the calls for additional booster shots to combat the COVID-19 pandemic is, from his perspective, increasingly troubling.
A Note to the Vaccinated: Thank You and Be Reassured
Recent headlines sparked fear after discussing waning immunity to SARS-CoV-2 after vaccination. In this op-ed, immunologist Michael Kinch addresses the subject of the articles and explains why it is normal for antibody levels in the blood to wane over time.
The Alpha and Omega of COVID-19: Yes, the Pandemic Will End (but Not Soon)
The omega of the pandemic is in sight. To achieve this, we must all work together not merely to develop these new technologies, but to ensure that they are widely and appropriately accepted by the public.
Unintended Consequences: The Risks of Vacating COVID-19 Vaccine Patents
In this op-ed piece, Michael S. Kinch, director of the Centers for Research Innovation in Biotechnology and Drug Discovery at Washington University in St. Louis, explores the issue of eliminating patent protection for COVID-19 vaccines.
The COVID-19 Whack-a-Mole
As the pandemic enters its second year, the case for optimism has grown shakier. SARS-CoV-2 has been mutating. New variants have arisen in the United Kingdom, Brazil and South Africa, and seem intent on evading our remarkable new vaccines before we’ve even fully rolled them out.